Medeon Biodesign, Inc. (TPEX:6499)

Medeon Biodesign Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	805.58	513.37	1,238	483.9	735.32	1,128
Short-Term Investments	93.17	652.18	862.1	1,025	1,608	1,058
Trading Asset Securities	38.62	41.66	41.93	37.87	6.48	-
Cash & Short-Term Investments	937.37	1,207	2,142	1,547	2,350	2,186
Cash Growth	-32.20%	-43.64%	38.44%	-34.16%	7.49%	21.44%
Accounts Receivable	46.84	37.84	41.77	32.35	10.12	164.81
Other Receivables	6.07	7.71	8.37	26.65	5.12	5.5
Receivables	52.91	45.55	50.15	59.01	15.25	170.31
Inventory	25.47	34.1	10.77	10.06	-	45.48
Prepaid Expenses	25.57	30.34	24.89	21.42	24.68	17.75
Total Current Assets	1,041	1,317	2,228	1,638	2,390	2,420
Property, Plant & Equipment	285.48	355.47	321.82	340.24	44.52	666.03
Long-Term Investments	-	-	-	1,876	1,847	-
Goodwill	-	106.74	106.74	106.74	39.23	72.19
Other Intangible Assets	154.53	55.01	64.33	73.44	39.71	141.33
Long-Term Deferred Tax Assets	32.95	32.95	-	-	-	4.12
Other Long-Term Assets	5.28	10.37	26.46	5.59	4.58	10.93
Total Assets	1,520	1,878	2,747	4,040	4,364	3,314
Accounts Payable	12.84	12	5.36	3.94	0.05	28.26
Accrued Expenses	-	113.03	98.01	73.09	68.33	73.19
Current Portion of Leases	41.68	54.56	47.15	36.69	14.53	23.53
Current Income Taxes Payable	-	-	37.97	56.78	66.74	41.75
Current Unearned Revenue	10.38	4.51	3.11	0.86	0.65	11.13
Other Current Liabilities	109.37	31.54	30.16	27.17	10	19.73
Total Current Liabilities	174.26	215.64	221.76	198.51	160.3	197.59
Long-Term Debt	-	-	-	-	-	12.94
Long-Term Leases	83.39	113.84	139.59	162.22	15.71	456.3
Long-Term Deferred Tax Liabilities	10.9	12.36	14.31	15.74	-	-
Total Liabilities	268.55	341.84	375.65	376.48	176	666.83
Common Stock	922.45	922.45	922.45	878.4	732.34	665.03
Additional Paid-In Capital	1,342	1,339	1,341	1,344	1,349	1,933
Retained Earnings	-1,359	-792.94	31.25	1,355	2,072	-525.91
Treasury Stock	-	-5.25	-10.6	-10.6	-10.6	-20.48
Comprehensive Income & Other	268.04	56.73	36.18	30.94	-12.49	-6.68
Total Common Equity	1,173	1,520	2,320	3,597	4,130	2,045
Minority Interest	77.6	15.71	51.51	66.1	58.15	602.47
Shareholders' Equity	1,251	1,536	2,371	3,664	4,188	2,648
Total Liabilities & Equity	1,520	1,878	2,747	4,040	4,364	3,314
Total Debt	125.06	168.4	186.74	198.91	30.24	492.76
Net Cash (Debt)	812.31	1,039	1,955	1,348	2,320	1,693
Net Cash Growth	-32.49%	-46.87%	45.01%	-41.87%	36.98%	0.68%
Net Cash Per Share	8.81	11.27	21.24	14.65	25.19	18.48
Filing Date Shares Outstanding	92	92.14	92.04	92.02	92.02	91.63
Total Common Shares Outstanding	92	92.14	92.04	92.02	92.02	91.63
Working Capital	867.06	1,102	2,006	1,439	2,230	2,222
Book Value Per Share	12.75	16.50	25.21	39.10	44.89	22.32
Tangible Book Value	1,019	1,358	2,149	3,417	4,051	1,832
Tangible Book Value Per Share	11.08	14.74	23.35	37.14	44.03	19.99
Machinery	-	229.55	178.49	168.97	46.34	239.52
Leasehold Improvements	-	84.96	46.22	45.6	6.43	74.41

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.